View in EDS HTML Full Text PDF Full Text

Early-phase amyloid PET reproduces metabolic signatures of cognitive decline in Parkinson's disease.

Saved in:
Bibliographic Details
Title: Early-phase amyloid PET reproduces metabolic signatures of cognitive decline in Parkinson's disease.
Authors: Aye WWT; New Zealand Brain Research Institute Christchurch New Zealand.; Department of Medicine University of Otago Christchurch New Zealand., Stark MR; New Zealand Brain Research Institute Christchurch New Zealand., Horne KL; New Zealand Brain Research Institute Christchurch New Zealand.; Department of Medicine University of Otago Christchurch New Zealand., Livingston L; New Zealand Brain Research Institute Christchurch New Zealand., Grenfell S; New Zealand Brain Research Institute Christchurch New Zealand., Myall DJ; New Zealand Brain Research Institute Christchurch New Zealand., Pitcher TL; New Zealand Brain Research Institute Christchurch New Zealand.; Department of Medicine University of Otago Christchurch New Zealand., Almuqbel MM; New Zealand Brain Research Institute Christchurch New Zealand.; Radiology Holding Company New Zealand Christchurch New Zealand., Keenan RJ; New Zealand Brain Research Institute Christchurch New Zealand.; Radiology Holding Company New Zealand Christchurch New Zealand., Meissner WG; New Zealand Brain Research Institute Christchurch New Zealand.; CHU Bordeaux, Service de Neurologie des Maladies Neurodégénératives IMNc, NS-Park/FCRIN Network Bordeaux France.; Univ. Bordeaux, CNRS, IMN Bordeaux France., Dalrymple-Alford JC; New Zealand Brain Research Institute Christchurch New Zealand.; School of Psychology, Speech and Hearing, University of Canterbury, Psychology Speech and Hearing Arts Road, Ilam Christchurch New Zealand., Anderson TJ; New Zealand Brain Research Institute Christchurch New Zealand.; Department of Medicine University of Otago Christchurch New Zealand.; Department of Neurology Canterbury District Health Board Christchurch New Zealand., Heron CL; New Zealand Brain Research Institute Christchurch New Zealand.; Department of Medicine University of Otago Christchurch New Zealand.; School of Psychology, Speech and Hearing, University of Canterbury, Psychology Speech and Hearing Arts Road, Ilam Christchurch New Zealand.; Department of Neurology Canterbury District Health Board Christchurch New Zealand., Melzer TR; New Zealand Brain Research Institute Christchurch New Zealand.; Department of Medicine University of Otago Christchurch New Zealand.; Radiology Holding Company New Zealand Christchurch New Zealand.; School of Psychology, Speech and Hearing, University of Canterbury, Psychology Speech and Hearing Arts Road, Ilam Christchurch New Zealand.
Source: Alzheimer's & dementia (Amsterdam, Netherlands) [Alzheimers Dement (Amst)] 2024 Jun 22; Vol. 16 (2), pp. e12601. Date of Electronic Publication: 2024 Jun 22 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Wiley on behalf of the Alzheimer's Association Country of Publication: United States NLM ID: 101654604 Publication Model: eCollection Cited Medium: Print ISSN: 2352-8729 (Print) Linking ISSN: 23528729 NLM ISO Abbreviation: Alzheimers Dement (Amst) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38912306
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Early-phase amyloid PET reproduces metabolic signatures of cognitive decline in Parkinson's disease.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Aye+WWT%22">Aye WWT</searchLink>; New Zealand Brain Research Institute Christchurch New Zealand.; Department of Medicine University of Otago Christchurch New Zealand.<br /><searchLink fieldCode="AU" term="%22Stark+MR%22">Stark MR</searchLink>; New Zealand Brain Research Institute Christchurch New Zealand.<br /><searchLink fieldCode="AU" term="%22Horne+KL%22">Horne KL</searchLink>; New Zealand Brain Research Institute Christchurch New Zealand.; Department of Medicine University of Otago Christchurch New Zealand.<br /><searchLink fieldCode="AU" term="%22Livingston+L%22">Livingston L</searchLink>; New Zealand Brain Research Institute Christchurch New Zealand.<br /><searchLink fieldCode="AU" term="%22Grenfell+S%22">Grenfell S</searchLink>; New Zealand Brain Research Institute Christchurch New Zealand.<br /><searchLink fieldCode="AU" term="%22Myall+DJ%22">Myall DJ</searchLink>; New Zealand Brain Research Institute Christchurch New Zealand.<br /><searchLink fieldCode="AU" term="%22Pitcher+TL%22">Pitcher TL</searchLink>; New Zealand Brain Research Institute Christchurch New Zealand.; Department of Medicine University of Otago Christchurch New Zealand.<br /><searchLink fieldCode="AU" term="%22Almuqbel+MM%22">Almuqbel MM</searchLink>; New Zealand Brain Research Institute Christchurch New Zealand.; Radiology Holding Company New Zealand Christchurch New Zealand.<br /><searchLink fieldCode="AU" term="%22Keenan+RJ%22">Keenan RJ</searchLink>; New Zealand Brain Research Institute Christchurch New Zealand.; Radiology Holding Company New Zealand Christchurch New Zealand.<br /><searchLink fieldCode="AU" term="%22Meissner+WG%22">Meissner WG</searchLink>; New Zealand Brain Research Institute Christchurch New Zealand.; CHU Bordeaux, Service de Neurologie des Maladies Neurodégénératives IMNc, NS-Park/FCRIN Network Bordeaux France.; Univ. Bordeaux, CNRS, IMN Bordeaux France.<br /><searchLink fieldCode="AU" term="%22Dalrymple-Alford+JC%22">Dalrymple-Alford JC</searchLink>; New Zealand Brain Research Institute Christchurch New Zealand.; School of Psychology, Speech and Hearing, University of Canterbury, Psychology Speech and Hearing Arts Road, Ilam Christchurch New Zealand.<br /><searchLink fieldCode="AU" term="%22Anderson+TJ%22">Anderson TJ</searchLink>; New Zealand Brain Research Institute Christchurch New Zealand.; Department of Medicine University of Otago Christchurch New Zealand.; Department of Neurology Canterbury District Health Board Christchurch New Zealand.<br /><searchLink fieldCode="AU" term="%22Heron+CL%22">Heron CL</searchLink>; New Zealand Brain Research Institute Christchurch New Zealand.; Department of Medicine University of Otago Christchurch New Zealand.; School of Psychology, Speech and Hearing, University of Canterbury, Psychology Speech and Hearing Arts Road, Ilam Christchurch New Zealand.; Department of Neurology Canterbury District Health Board Christchurch New Zealand.<br /><searchLink fieldCode="AU" term="%22Melzer+TR%22">Melzer TR</searchLink>; New Zealand Brain Research Institute Christchurch New Zealand.; Department of Medicine University of Otago Christchurch New Zealand.; Radiology Holding Company New Zealand Christchurch New Zealand.; School of Psychology, Speech and Hearing, University of Canterbury, Psychology Speech and Hearing Arts Road, Ilam Christchurch New Zealand.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101654604%22">Alzheimer's & dementia (Amsterdam, Netherlands)</searchLink> [Alzheimers Dement (Amst)] 2024 Jun 22; Vol. 16 (2), pp. e12601. <i>Date of Electronic Publication: </i>2024 Jun 22 (<i>Print Publication: </i>2024).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley+on+behalf+of+the+Alzheimer's+Association%22">Wiley on behalf of the Alzheimer's Association </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101654604 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2352-8729 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223528729%22">23528729 </searchLink><i>NLM ISO Abbreviation: </i>Alzheimers Dement (Amst) <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38912306
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/dad2.12601
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e12601
    Titles:
      – TitleFull: Early-phase amyloid PET reproduces metabolic signatures of cognitive decline in Parkinson's disease.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Aye WWT
      – PersonEntity:
          Name:
            NameFull: Stark MR
      – PersonEntity:
          Name:
            NameFull: Horne KL
      – PersonEntity:
          Name:
            NameFull: Livingston L
      – PersonEntity:
          Name:
            NameFull: Grenfell S
      – PersonEntity:
          Name:
            NameFull: Myall DJ
      – PersonEntity:
          Name:
            NameFull: Pitcher TL
      – PersonEntity:
          Name:
            NameFull: Almuqbel MM
      – PersonEntity:
          Name:
            NameFull: Keenan RJ
      – PersonEntity:
          Name:
            NameFull: Meissner WG
      – PersonEntity:
          Name:
            NameFull: Dalrymple-Alford JC
      – PersonEntity:
          Name:
            NameFull: Anderson TJ
      – PersonEntity:
          Name:
            NameFull: Heron CL
      – PersonEntity:
          Name:
            NameFull: Melzer TR
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 22
              M: 06
              Text: 2024 Jun 22
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 2352-8729
          Numbering:
            – Type: volume
              Value: 16
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Alzheimer's & dementia (Amsterdam, Netherlands)
              Type: main
ResultId 1